Providence Autologous Stem Cell Transplant Program

Providence Autologous Stem Cell Transplant Program offers treatment for a broad range of diseases, including non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myelomaacute leukemia and testicular cancer.

Our program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), which allows us to participate in transplant protocols (clinical trials) through the Bone Marrow Transplant Clinical Trials Network and National Clinical Trials Network

For more information about our transplant related services: